Pathogenic effects of cancer-associated mutations in IRF4

Pathogenic effects of cancer-associated mutations in IRF4

group Group
The Enders Group - Models of Human Primary Immunodeficiencies
traffic Project status
Current

Content navigation

About

Pathogenic effects of cancer-associated mutations in IRF4

Members

Supervisor

Anselm Enders

Associate Professor Anselm Enders

Head of Division, Immunology & Infectious Diseases
Senior Research Fellow
Group Leader, Enders Group